Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2461 – 2480 of 3236

Drug-Drug Interactions: Protease Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-protease-inhibitors

Laboratory Testing: Drug-Resistance Testing

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-resistance-testing

Diagnosis of HIV Infection in Infants and Children

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-diagnosis-hiv-infection-children

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/introduction

Laboratory Testing: HLA-B* 5701 Screening

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hla-b-5701-screening

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/introduction

Saquinavir (Invirase, SQV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-saquinavir-invirase

Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-insti

Bacterial Enteric Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/bacterial-enteric

Discontinuation or Interruption of Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/discontinuation-or-interruption-antiretroviral-therapy

Cryptosporidiosis

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cryptosporidiosis

Cystoisosporiasis (Formerly Isosporiasis)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cystoisosporiasis

Fixed-Dose Combinations

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/fixed-dose-combinations

Etravirine (Intelence, ETR)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-etravirine-intelence

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/nucleoside-and-nucleotide-analogue-reverse

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/zidovudine

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/figures

Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-nrti

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/toxoplasmosis

Pharmacoenhancers

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/pharmacoenhancers